MedPath

survey to rule out the occurrence of dry mouth and related problems in head and neck cancer

Not Applicable
Conditions
Health Condition 1: null- xersotomia in head and neck cancer
Registration Number
CTRI/2017/04/008372
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1) Age group: - 18 and above

2) Patients who have received radical external beam radiotherapy (EBRT) with or without concurrent chemotherapy.

3) Those who have completed all planned treatment and have come on their first follow up (8-12 weeks after completion of EBRT.

4) Willing to participate in the study.

Exclusion Criteria

1) Patients receiving adjuvant RT.

2) Patients who have received a combination of EBRT and Brachytherapy or Brachytherapy alone.

3) Metastatic cancer.

4) Co-morbid condition such as DM, antidepressants, Sâ??jogren syndrome.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
60% prevalence of xerostomia in patients who have received radiation therapy for head and neck cancer by using Groninge xerostomia inventoryTimepoint: February, 2017
Secondary Outcome Measures
NameTimeMethod
50% prevalence of xerostomia related problems such as dental caries, reduced sleep, dysphagia and anorexiaTimepoint: March,2017
© Copyright 2025. All Rights Reserved by MedPath